Life Sciences Tools and Services
Company Overview of National Institutes of Health
National Institutes of Health operates as a medical research agency in the United States. It offers services for conducting and supporting basic, clinical, and translational medical research; and investigates the causes, treatments, and cures for common and rare diseases. The company also provides leadership and direction to programs designed to improve the health by conducting and supporting research in the causes, diagnosis, prevention, and cure of human diseases; in the processes of human growth and development; in the biological effects of environmental contaminants; in the understanding of mental, addictive, and physical disorders; and in directing programs for the collection, dissemina...
9000 Rockville Pike
Bethesda, MD 20892
Founded in 1887
Key Executives for National Institutes of Health
Chief Financial Officer and Deputy Director of Management
Chief Information Officer
Compensation as of Fiscal Year 2016.
National Institutes of Health Key Developments
SELLAS Life Sciences Group Announces Entry Into Cooperative Research and Development Agreement with National Heart, Lung and Blood Institute and National Institutes of Health
Sep 14 16
SELLAS Life Sciences Group announced that it has entered into a Cooperative Research and Development Agreement with the National Heart, Lung and Blood Institute, National Institutes of Health. The research plan of the CRADA is designed to develop a novel AML MRD assay for monitoring the expression of multiple genes (including WT1) that can document the kinetics of minimal residual disease (MRD) in acute myeloid leukemia during treatment with SELLAS' most advanced product candidate, galinpepimut-S, the Company's WT1 cancer vaccine. SELLAS plans to commence a pivotal Phase 3 trial of galinpepimut-S in AML patients where this new AML-MRD assay will be used as a biomarker test. SELLAS will collaborate with Christopher S. Hourigan, DPhil, FACP, Chief of the Myeloid Malignancies Section, Hematology Branch, National Heart, Lung and Blood Institute (NHLBI), NIH, and Dr. Hourigan's research unit in this very promising research effort.
National Institutes of Health Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016
Sep 9 16
National Institutes of Health Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016 . Venue: The Westin Copley Place, 10 Huntington Ave, Boston, MA 02116, United States.
Albert Einstein College of Medicine and Montefiore in Collaboration with the City University of New York Receives $9.4 Million Grant from the National Institutes of Health
Aug 15 16
Albert Einstein College of Medicine and Montefiore, in collaboration with the City University of New York (CUNY), have received a $9.4 million grant from the National Institutes of Health (NIH) to lead research in Central Africa to improve clinical care and health outcomes for patients with HIV. The ongoing, five-country observational study, called Central Africa International Epidemiologic Databases to Evaluate AIDS (CA-IeDEA), involves more than 50,000 HIV-positive children and adults taking anti-retroviral therapy (ART). CA-IeDEA partners with the governments of five nations—Burundi, Cameroon, Rwanda, and the Democratic Republic of Congo—and will extend the collaboration to the Republic of Congo. Researchers and health workers based in each country regularly collect de-identified data from electronic medical records, which are integrated into an external database for analysis. Over the next five years, the team will increase the number of clinical sites involved in the study from 15 to 20 as CA-IeDEA expands into more rural areas.
Similar Private Companies By Industry
Recent Private Companies Transactions